2m 2m 2m 2m 2m 2m 2m
DESIGN THERAP (DSGN)
NASDAQ
$10.44+$0.27 (+2.61%)
Price as of Jun 03, 2026 4:10 PM EDT- $654.5MMarket Cap
- 153.62%1-Year Change
- BiotechnologyIndustry
DESIGN THERAP (DSGN)
$10.44+$0.27 (+2.61%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 872,000 -2.13% | 891,000 -10.09% | 991,000 N/A | N/A N/A | |
Gross Profit | -872,000 -2.13% | -891,000 -10.09% | -991,000 N/A | 0 -100.00% | |
Sales and Marketing Expense | 528,000 -1.68% | 537,000 -0.19% | 538,000 N/A | N/A N/A | |
Research and Development Expense | -59.1M +33.32% | -44.4M -22.28% | -57.1M +17.38% | -48.6M +96.19% | |
Depreciation and Amortization Expense | 622,000 +4.36% | 596,000 +10.99% | 537,000 +32.27% | 406,000 +214.73% | |
Total Operating Expenses | 79.5M +27.39% | 62.4M -20.22% | 78.2M +15.68% | 67.6M +88.64% | |
Operating Profit | -79.5M +27.39% | -62.4M -20.22% | -78.2M +15.68% | -67.6M +88.64% | |
Interest Income | 9.7M -24.38% | 12.8M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 9.7M -24.38% | 12.8M N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 11.3M +164.36% | 4.3M +1,337.92% | |
Income before Taxes | -79.5M +27.39% | -62.4M -20.22% | -78.2M +15.68% | -67.6M +88.64% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -69.8M +40.74% | -49.6M -25.84% | -66.9M +5.61% | -63.3M +78.17% | |
Net Income from Continuing Operations Applicable to Common | -69.8M +40.74% | -49.6M -25.84% | -66.9M +5.61% | -63.3M +78.17% | |
Basic EPS and Net Income | -1.22 +38.64% | -0.88 -26.05% | -1.19 +4.39% | -1.14 +48.05% | |
Diluted EPS and Net Income | -1.22 +38.64% | -0.88 -26.05% | -1.19 +4.39% | -1.14 +48.05% | |
Basic Weighted Average Shares | 57.3M +1.31% | 56.6M +1.08% | 56.0M +0.50% | 55.7M +21.27% | |
Diluted Weighted Average Shares | 57.3M +1.31% | 56.6M +1.08% | 56.0M +0.50% | 55.7M +21.27% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 16.9M -25.29% | 22.6M +6.43% | 21.2M -20.00% | 26.5M -91.12% | |
Short-Term Investments | 203.0M -8.94% | 222.9M -14.46% | 260.6M -14.25% | 303.9M +255.44% | |
Cash and Cash Equivalents and Short-Term Investments | 219.8M -10.44% | 245.5M -12.89% | 281.8M -14.71% | 330.4M -13.98% | |
Total Current Assets | 223.8M -9.78% | 248.0M -12.84% | 284.6M -15.08% | 335.1M -13.05% | |
Accumulated Depreciation | 2.3M +36.80% | 1.7M +56.28% | 1.1M +102.87% | 522,000 +289.55% | |
Property and Plant and Equipment and Net | 981,000 -30.43% | 1.4M -16.62% | 1.7M -13.15% | 1.9M +29.11% | |
Total Long-Term Assets | 0 -100.00% | 427,000 -0.70% | 430,000 -6.32% | 459,000 -73.31% | |
Total Assets | 226.2M -10.27% | 252.1M -12.96% | 289.6M -15.09% | 341.1M -12.65% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 13.1M +54.28% | 8.5M -12.06% | 9.6M -10.71% | 10.8M +103.98% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 645,000 -57.95% | 1.5M -34.28% | 2.3M -23.50% | 3.1M +2,004.14% | |
Total Liabilities | 13.7M +37.05% | 10.0M -16.39% | 12.0M -13.53% | 13.8M +64.08% | |
Retained Earnings | -297.0M +30.72% | -227.2M +27.92% | -177.6M +60.36% | -110.8M +133.40% | |
Total Stockholders Equity | 212.5M -12.22% | 242.1M -12.82% | 277.7M -15.16% | 327.3M -14.35% | |
Total Shares Outstanding | 60.4M +6.42% | 56.8M +0.50% | 56.5M +1.03% | 55.9M +0.82% | |
Cash Flow | |||||
Cash from Operating Activities | -54.4M +26.11% | -43.1M -26.39% | -58.6M +14.11% | -51.3M +74.68% | |
Capital Expenditures | 193,000 -43.24% | 340,000 +32.81% | 256,000 -72.11% | 918,000 -40.31% | |
Cash from Investing Activities | 22.9M -47.87% | 44.0M -16.33% | 52.5M +123.77% | -221.0M +311.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 25.7M +4,917.15% | 513,000 -29.14% | 724,000 +208.09% | 235,000 -99.94% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -29.18% +59.41% | -18.31% -13.64% | -21.20% +22.51% | -17.30% N/A | |
Return on Equity | -30.70% +60.92% | -19.08% -13.68% | -22.10% +23.85% | -17.85% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 17.14 -41.52% | 29.31 -0.89% | 29.58 -4.89% | 31.10 N/A | |
Cash Ratio | 1.29 -51.58% | 2.67 +21.02% | 2.20 -10.41% | 2.46 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow